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mouse IgG, PE-Cy5 labeled mouse IgG1 and PE labeled mouse 
IgG1. 
Results: Endothelial microparticles were significantly 
elevated in patients with HNC patients 
(CD31+/CD62E+/CD42b-: mean 1601±1479 EMP/µl; 
CD31+/CD142+/CD42b-: mean 121±135 EMP/µl) compared 
with control group (CD31+/CD62E+/CD42b-: mean 782±698 
EMP/µl; CD31+/CD142+/CD42b-: mean 688±647 EMP/µl). The 
concentration of EMP were not notably increased as result of 
RT/RCT (CD31+/CD62E+/CD42b-: mean 1629±769; 
EMP/µl;CD31+/CD142+/CD42b-: mean 1257±603 EMP/µl). 
There were no significant differences between EMP level 
before treatment, one day and 3 months after radiation 
cessation. Furthermore, there was no significant difference 
in plasma EMP level in plasma of the HNC patient undergoing 
RT alone, RT combined with chemotherapy, postoperative RT 
or postoperative RCT. 
Conclusions: The data suggest that the release of EMP is not 
a marker of ECs activation as a result of early response to 
ionizing radiation during RT/RCT in HNC patients. 
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Purpose/Objective: Prediction of the treatment response 
and overall outcome in patients is an important goal in 
radiation oncology. We aim to identify prognostic molecular 
features using gene expression profiling in gliomas. 
Materials and Methods: Data from [1] were used in this 
study. Total 152 samples including 100 glioblastomas, 21 
anaplastic astrocytomas, 19 diffuse astrocytomas and 12 
anaplastic oligodendrogliomas were selected for analysis and 
3456 genes expressed in gliomas, including 3012 unique 
sequences plus an additional 444 genes from a literature 
survey were identified. Different from using a selected 
training set in [1], the total 152 samples were included in our 
study. Progression–free survival (PFS) period was adopted as 
the clinical parameter for the treatment response. Pearson's 
linear correlation coefficients between the gene data and 
PFS record were computed for selecting the candidate genes 
for prognosis model. Hierarchical clustering was then 
computed based on the expression profile of selected genes. 
Cox proportional hazards regression was used to calculate the 
hazard ratios between different groups. 
Results: 47 genes are selected for our prognosis model and 
we have 29 genes in common with results in [1]. The 
unsupervised hierarchical clustering allows us to cluster the 
152 patients into three distinct groups based on their 
similarities measured over those selected 47 genes. The 
results of Kaplan-Meier analysis for all patients show PFS 
probabilities after 5 years are 70.2%, 0% and 25.7% for group 
1, 2 and 3 respectively. The cox proportional hazards 
regression analyses show hazard ratios 23.0, 8.8 and 0.6 for 
group 1&2, group 1&3 and group 2&3 respectively. The same 
method is also applied on the non-glioblastoma patients, 
which are able to be clustered into two groups with PFS 
probabilities after 5 years 76.0% and 0% for group 1 and 2 
respectively. The hazard ratio is calculated to be 25.5. 
 
 
 
Conclusions: In our analyses, the selected profiling results 
are useful in constructing a classification scheme and the 
unsupervised clustering method also succeeds in dividing the 
samples into good and poor prognosis groups. Compared with 
the results in [1], the good prognosis group in our result has 
higher PFS probabilities after 5 years and the unsupervised 
method is direct and easy to prevent the possible bias in the 
selection of training set in the supervised method. 
[1] M. Shirahata, S. Oba, K. Iwao-Koizumi, S. Saito, N. Ueno, 
M. Oda, N. Hashimoto, S. Ishii, J. A. Takahashi and K. Kato, 
Cancer Sci, 100: 165-172  
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Purpose/Objective: Comparison of theoretical estimation of 
lethal DNA damage of normal mammalian cells during 
exposure to low-kV X-rays with an ex vivo assessment of 
double-strand strand breaks (DSBs) in tissue irradiated in 
vivo. 
Materials and Methods: 130 patients were treated with 
Intrabeam intraoperative radiotherapy of the tumour bed 
following breast cancer resection. Tissue samples were taken 
from the resection wall before and after irradiation with 50 
kV X-rays. Doses of 5 to 6 Gy were delivered at 1 cm from the 
edge of a treatment applicator. Time for dose delivery varied 
between 10 and 40 minutes. Tissue samples were sectioned 
and stained for phosphorylated γH2Ax, representative of DNA 
repair, to assess damage before and after irradiation. The 
proportion of stain was recorded on multiple slides spanning 
samples from 130 patients. Monte Carlo radiation transport 
calculations were used to determine the spectra of secondary 
electrons at the samples in situ. These spectra were used as 
input to a damage simulation code producing expected levels 
of damage. In combination with expected repair rates and 
irradiation times, theoretical estimates of DSBs remaining at 
the end of irradiation were made based on the linear-
quadratic model of radiation damage with repair. 
Results: Considerable variability was found in change in 
γH2Ax expression between pre and post-irradiation sections, 
though there is a trend for decreased accumulation with 
longer irradiation time, consistent with increased 
proportional repair. The theoretical results suggest a 
reduction in damage with increasing applicator size due to 
both increased beam hardening and longer irradiation times. 
There is however little similarity between theoretical and 
experimental determination of induced DSBs, with poor 
correlation as shown in the figure. 
 
 
Conclusions: Assessment of DNA damage occurring in humans 
is difficult and rare. We found poor correlation between 
theoretical DSB estimates and those made using ex vivo 
assessment of tissue samples. It is likely that insufficient 
time was available post irradiation for accumulation and 
equilibrium of γH2Ax. With potentially slow repair and a 
diversity of cell types present in sections, larger numbers of 
patients may allow differences in in vivo normal tissue repair 
with dose-rate to be distinguished above levels of noise and 
uncertainty in both the measurements and the model. 
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Purpose/Objective: Glioblastomas (GBM) are some highly 
lethal brain tumors despite a conventional treatment 
associating surgical resection and subsequent radio-
chemotherapy. Amongst these heterogeneous tumors, a 
subpopulation of chemo- and radioresistant GBM stem-like 
cells appears to be involved in the systematic GBM 
recurrence. Moreover, recent studies showed that 
differentiated tumor cells may have the ability to 
dedifferentiate and acquire a stem-like phenotype, a 
phenomenon also called plasticity, in response to 
microenvironment stresses such as hypoxia. We hypothesized 
that GBM cells could be subjected to a similar 
dedifferentiation process after ionizing radiations (IR), then 
supporting the GBM rapid recurrence after radiotherapy. 
Materials and Methods: In the present study we established 
several differentiated GBM cell lines isolated from patient 
resections and subjected them to a clinically relevant IR dose 
(3 Gy). We then characterized, after long term culture, the 
phenotypic and functional alterations displayed by these GBM 
cells using in vitro techniques (qPCR, western blot, flow 
cytometry, limiting dilution clonogenic assays) and in vivo 
experiments (orthotopically-xenografted nude mice). 
Results: We demonstrated that the exposure of 
differentiated GBM cells to a subtoxic IR dose potentiated the 
long-term reacquisition of stem-associated properties such as 
the ability to generate primary and secondary neurospheres, 
the expression of stemness markers and an increased 
tumorigenicity. We also identified during this process an up-
regulation of the anti-apoptotic protein survivin and we 
showed that its down-regulation by YM-155, a selective 
survivin inhibitor used in anti-cancer clinical trials, led to the 
blockade of the IR-induced plasticity.  
Conclusions: Altogether, these results demonstrated that 
irradiation could regulate GBM cell dedifferentiation via a 
survivin-dependent pathway. Targeting the mechanisms 
associated with IR-induced plasticity will likely contribute to 
develop some innovating pharmacological strategies for an 
improved radiosensitization of these aggressive brain 
cancers. 
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